PNC Financial Services Group
PNT

PNC Financial Services Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

PNC Financial Services Group’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$1.45K – 4864
2023
Q1 		$1.45K Hold
200
– – ﹤0.01% 4373
2022
Q4 		$1.46K Hold
200
– – ﹤0.01% 4332
2022
Q3 		$2K Hold
200
– – ﹤0.01% 4230
2022
Q2 		$2K Hold
200
– – ﹤0.01% 4260
2022
Q1 		$2K Hold
200
– – ﹤0.01% 4251
2021
Q4 		$2K Buy
+200
New +$1.5K ﹤0.01% 4212

Other funds holding PNT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's PNT Position: Q2 2023 in Review

PNC Financial Services Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q2 2023, closing a stake of 200 shares — an estimated $1.45K sold.

PNC Financial Services Group first reported a position in PNT in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 130 funds tracked by Wall St. Rank hold PNT as of Q2 2023.

  • PNC Financial Services Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 200 POINT Biopharma Global Inc. Common Stock shares in Q2 2023, an estimated $1.45K.
  • PNC Financial Services Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • PNC Financial Services Group's POINT Biopharma Global Inc. Common Stock position peaked at $2K in Q3 2022.
  • 130 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q2 2023.

Based on PNC Financial Services Group's 13F filing for Q2 2023, filed 11 Aug 2023.